Having a right regulatory affair strategy and approach to Chinese market is quite key. When you have the plan to introduce the clinical stage projects or register the overseas' launched products to Chinese markets, Angine could work as your China RA partner by providing the services as follows:  

• Regulatory affairs strategy plotting 

• The expert meeting arrangement with NPMA or China CDE

• The right CRO recommendation

• The dossier preparation and submission

• Updating the registration progress and arrange the TC with regulatory experts if the additional questions needing addressed

• Other additional services